CIK: 0001799883 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $457,812 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PEAR THERAPEUTICS INC | 18,631,771 | $94,090 | 20.6% | $6.20 | — | CLASS A COM | 704723105 |
| — | CINCOR PHARMA INC | 4,337,646 | $76,082 | 16.6% | $17.54 | — | COM | 17240Y109 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $41,395 | 9.0% | $17.12 | — | COM | 29384C108 |
| — | VOR BIOPHARMA INC | 6,361,723 | $38,425 | 8.4% | $43.10 | — | COM | 929033108 |
| — | RALLYBIO CORP | 3,980,724 | $27,785 | 6.1% | $17.58 | — | COM | 75120L100 |
| ARVN | ARVINAS INC | 400,000 | $26,920 | 5.9% | $29.28 | +132.8% | COM | 04335A105 |
| — | SCPHARMACEUTICALS INC | 3,831,474 | $21,763 | 4.8% | $5.92 | — | COM | 810648105 |
| — | AKOUOS INC | 4,135,784 | $19,645 | 4.3% | $22.50 | — | COM | 00973J101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 862,286 | $18,927 | 4.1% | $19.04 | +6.3% | COM | 22663K107 |
| — | IMPEL NEUROPHARMA INC | 2,884,791 | $18,376 | 4.0% | $8.85 | — | COM | 45258K109 |
| — | IVERIC BIO INC | 1,027,874 | $17,299 | 3.8% | $16.46 | — | COM | 46583P102 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,398,066 | $15,644 | 3.4% | $7.13 | +106.6% | COM | 45166A102 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $13,789 | 3.0% | $20.70 | — | COM | 438083107 |
| RNAM | AVIDITY BIOSCIENCES INC | 390,555 | $7,214 | 1.6% | $21.74 | -21.8% | COM | 05370A108 |
| JANX | JANUX THERAPEUTICS INC | 446,266 | $6,399 | 1.4% | $22.27 | -26.5% | COM | 47103J105 |
| COGT | COGENT BIOSCIENCES INC | 711,412 | $5,328 | 1.2% | $6.96 | 0.0% | COM | 19240Q201 |
| CABA | CABALETTA BIO INC | 2,064,263 | $4,190 | 0.9% | $11.85 | -77.9% | COM | 12674W109 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3,596 | 0.8% | $10.17 | — | COM CL A | 33836P105 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $945 | 0.2% | $3.84 | — | COM | 171757107 |